Quark Pharmaceuticals, Inc.
http://www.quarkpharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Quark Pharmaceuticals, Inc.
IPOs Are Back: Liquid Biopsy, Cardio, Dialysis Firms Lead $1.5Bn Charge
Who wants to go public during a once-in-a-century crisis? It seems like quite a few medtechs do.
Renalytix AI And AstraZeneca Collaborate To Improve Chronic Kidney Disease Outcomes
The companies will launch "precision medicine strategies" for chronic disease that use Renalytix' AI-enabled IVDs.
Renalytix AI Launches Trial To Identify COVID-19 Patients With Kidney Injury
The Mount Sinai spin-off believes its KindeyIntelX system can identify COVID-19 patients at high risk for long-term kidney damage.
Regulatory, Security Concerns Force Wuxi NextCODE To Cut China Ties
As China tightens its grip over clinical research using human genetic data in the country, and the US increases scrutiny over the use of personal data, multinational drug developers may face a difficult choice or even create separate entities to cater to local regulatory requirements. WuXi NextCODE provides one interesting case study.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule